{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:24:27Z","timestamp":1793798667088,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.neurol.2023.03.009","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T08:18:57Z","timestamp":1680596337000},"page":"417-424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Stroke and cancer"],"prefix":"10.1016","volume":"179","author":[{"given":"M.","family":"Zuber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2023.03.009_bib0250","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.11.016","article-title":"Trends in cancer diagnoses among inpatients hospitalized with stroke","volume":"22","author":"Sanossian","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.neurol.2023.03.009_bib0255","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.02.006","article-title":"Predictors of occult cancer in acute ischemic stroke patients","volume":"24","author":"Cocho","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.neurol.2023.03.009_bib0260","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000440730","article-title":"Cancer-associated stroke: the Bergen NORSTROKE study","volume":"5","author":"Selvik","year":"2015","journal-title":"Cerebrovasc Dis Extra"},{"key":"10.1016\/j.neurol.2023.03.009_bib0265","doi-asserted-by":"crossref","first-page":"e2025","DOI":"10.1212\/WNL.0000000000005636","article-title":"New diagnosis of cancer and the risk of subsequent cerebrovascular events","volume":"90","author":"Navi","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.03.009_bib0270","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","article-title":"Risk of arterial thromboembolism in patients with cancer","volume":"70","author":"Navi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.neurol.2023.03.009_bib0275","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000484668","article-title":"When to screen ischaemic stroke patients for cancer","volume":"45","author":"Selvik","year":"2018","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.neurol.2023.03.009_bib0280","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/STROKEAHA.120.032002","article-title":"Cancer and embolic stroke of undetermined source","volume":"52","author":"Navi","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2023.03.009_bib0285","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/acn3.291","article-title":"Characteristics of cryptogenic stroke in cancer patients","volume":"3","author":"Gon","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2023.03.009_bib0290","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00005792-198501000-00002","article-title":"Cerebrovascular complications in patients with cancer","volume":"64","author":"Graus","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.neurol.2023.03.009_bib0295","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.25227","article-title":"Ischemic stroke in cancer patients: a review of an underappreciated pathology","volume":"83","author":"Navi","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2023.03.009_bib0300","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ana.22050","article-title":"Coagulopathy and embolic signal in cancer patients with ischemic stroke","volume":"68","author":"Seok","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2023.03.009_bib0305","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.ejca.2012.01.005","article-title":"Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden","volume":"48","author":"Z\u00f6ller","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.neurol.2023.03.009_bib0310","first-page":"1039","article-title":"Stroke and cancer\u00a0\u2013\u00a0a complicated relationship","volume":"2","author":"Dearborn","year":"2014","journal-title":"J Neurol Transl Neurosci"},{"key":"10.1016\/j.neurol.2023.03.009_bib0315","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/jth.13903","article-title":"Cancer and risk of cerebral venous thrombosis: a case-control study","volume":"16","author":"Silvis","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.neurol.2023.03.009_bib0320","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/STROKEAHA.117.019483","article-title":"Cerebral venous thrombosis in older patients","volume":"49","author":"Zuurbier","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2023.03.009_bib0325","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/bjh.13162","article-title":"Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia\u00a0\u2013\u00a0a multicentre study from the Nordic Society of Paediatric Haematology and Oncology","volume":"168","author":"Ranta","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.neurol.2023.03.009_bib0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17562864221106362","article-title":"Cancer and stroke: commonly encountered by clinicians, but little evidence to guide clinical approach","volume":"15","author":"Woock","year":"2022","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.neurol.2023.03.009_bib0330","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.arcmed.2017.03.005","article-title":"Atherosclerosis and cancer: a resemblance with far-reaching implications","volume":"48","author":"Tapia-Vieyra","year":"2017","journal-title":"Arch Med Res"},{"key":"10.1016\/j.neurol.2023.03.009_bib0490","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/WNF.0000000000000310","article-title":"Increased risk of ischemic stroke in multiple myeloma associated with lenalidomide treatment: a case report and review of the literature","volume":"41","author":"de Celis","year":"2018","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.neurol.2023.03.009_bib0335","first-page":"779","article-title":"Cancer-associated stroke: pathophysiology, detection and management (review)","volume":"54","author":"Dardiotis","year":"2019","journal-title":"Int J Oncol"},{"key":"10.1016\/j.neurol.2023.03.009_bib0340","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.thromres.2022.09.014","article-title":"Cancer and stroke: what do we know and where do we go?","volume":"219","author":"Lun","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.neurol.2023.03.009_bib0345","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.0000000000000539","article-title":"Recurrent thromboembolic events after ischemic stroke in patients with cancer","volume":"83","author":"Navi","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.03.009_bib0350","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11060-012-1011-4","article-title":"Clinical manifestation of cancer related stroke: retrospective case-control study","volume":"111","author":"Kim","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.neurol.2023.03.009_bib0355","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-007-9419-y","article-title":"Multifocal strokes as the presentation of occult lung cancer","volume":"85","author":"Navi","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1016\/j.neurol.2023.03.009_bib0360","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.01.007","article-title":"First-ever stroke as initial presentation of systemic cancer","volume":"17","author":"Taccone","year":"2008","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.neurol.2023.03.009_bib0365","doi-asserted-by":"crossref","first-page":"e44959","DOI":"10.1371\/journal.pone.0044959","article-title":"Clues to occult cancer in patients with ischemic stroke","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neurol.2023.03.009_bib0375","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1212\/CPJ.0000000000000603","article-title":"Three territory sign: an MRI marker of malignancy- related ischemic stroke (Trousseau syndrome)","volume":"9","author":"Nouh","year":"2019","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.neurol.2023.03.009_bib0380","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ana.25495","article-title":"Histological features of intracranial thrombi in stroke patients with cancer","volume":"86","author":"Park","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2023.03.009_bib0385","doi-asserted-by":"crossref","first-page":"930635","DOI":"10.3389\/fneur.2022.930635","article-title":"Absence of susceptibility vessel sign in patients with malignancy-related acute ischemic stroke treated with mechanical thrombectomy","volume":"13","author":"Beyeler","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurol.2023.03.009_bib0390","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/ijs.12124","article-title":"Ischemic stroke in patients with cancer: is it different from usual strokes?","volume":"9","author":"Lee","year":"2014","journal-title":"Int J Stroke"},{"key":"10.1016\/j.neurol.2023.03.009_bib0395","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/ene.12673","article-title":"Cryptogenic stroke","volume":"22","author":"Fonseca","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2023.03.009_bib0400","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.thromres.2018.03.011","article-title":"Cancer-associated ischemic stroke: a retrospective multicentre cohort study","volume":"165","author":"Grazioli","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.neurol.2023.03.009_bib0405","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2023.03.009_bib0410","first-page":"4795","article-title":"Efficacy and safety of intravenous thrombolysis for acute ischemic stroke in cancer patients: a systemic review and meta-analysis","volume":"12","author":"Huang","year":"2020","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.neurol.2023.03.009_bib0415","doi-asserted-by":"crossref","first-page":"105742","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105742","article-title":"Reperfusion therapy in acute ischemic stroke with active cancer: a meta-analysis aided by machine learning","volume":"30","author":"Eun","year":"2021","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.neurol.2023.03.009_bib0420","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/1747493019895709","article-title":"Contemporary utilization patterns and outcomes of thrombolytic administration for ischemic stroke among patients with cancer","volume":"16","author":"Owusu-Guha","year":"2021","journal-title":"Int J Stroke"},{"key":"10.1016\/j.neurol.2023.03.009_bib0425","doi-asserted-by":"crossref","first-page":"e993","DOI":"10.1212\/WNL.0000000000013316","article-title":"Clinical outcome after endovascular treatment in patients with active cancer and ischemic stroke: a MR CLEAN registry substudy","volume":"98","author":"Verschoof","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.03.009_bib0430","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/23969873221100897","article-title":"Endovascular treatment in patients with acute ischemic stroke and cancer: systematic review and meta-analysis","volume":"7","author":"Caimano","year":"2022","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.neurol.2023.03.009_bib0435","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/1747493020929943","article-title":"Discrepancy between post-treatment infarct volume and 90-day outcome in the ESCAPE randomized controlled trial","volume":"16","author":"Ganesh","year":"2021","journal-title":"Int J Stroke"},{"key":"10.1016\/j.neurol.2023.03.009_bib0440","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2023.03.009_bib0445","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/jth.15779","article-title":"Ischemic stroke with cancer: hematologic and embolic biomarkers and clinical outcomes","volume":"20","author":"Navi","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.neurol.2023.03.009_bib0450","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1200\/JOP.18.00592","article-title":"Atrial fibrillation and stroke risk in patients with cancer: a primer for oncologists","volume":"15","author":"Sorigue","year":"2019","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.neurol.2023.03.009_bib0455","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/bloodadvances.2017010694","article-title":"Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation","volume":"2","author":"Shah","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.neurol.2023.03.009_bib0460","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamaneurol.2017.4211","article-title":"Enoxaparin vs. aspirin in patients with cancer and ischemic stroke: the TEACH pilot randomized clinical trial","volume":"75","author":"Navi","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2023.03.009_bib0465","doi-asserted-by":"crossref","first-page":"502089","DOI":"10.1155\/2015\/502089","article-title":"Comparison of enoxaparin and warfarin for secondary prevention of cancer-associated stroke","volume":"2015","author":"Jang","year":"2015","journal-title":"J Oncol"},{"key":"10.1016\/j.neurol.2023.03.009_bib0470","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11060-016-2106-0","article-title":"Predictors of survival for patients with cancer after cryptogenic stroke","volume":"128","author":"Shin","year":"2016","journal-title":"J Neurooncol"},{"key":"10.1016\/j.neurol.2023.03.009_bib0475","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.07.029","article-title":"Treatment of cryptogenic stroke with active cancer with a new oral anticoagulant","volume":"26","author":"Nam","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.neurol.2023.03.009_bib0480","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/STROKEAHA.115.008694","article-title":"Cancer in young adults with ischemic stroke","volume":"46","author":"Aarnio","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2023.03.009_bib0485","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/WNL.0000000000001951","article-title":"Recurrent stroke in childhood cancer survivors","volume":"85","author":"Fullerton","year":"2015","journal-title":"Neurology"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723008913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723008913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:47:17Z","timestamp":1758520037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378723008913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0035378723008913"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2023.03.009","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stroke and cancer","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2023.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}